教室紹介

2018年業績集

受賞

  1. 欧州泌尿器科学会ベストポスター賞
    S. Yajima, S. Yoshida, T. Takahara, M. Yokoyama, J. Ishioka, Y. Matsuoka, K. Saito, K.
    Kihara, Y. Fujii. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. "Best Poster Presentation", The 33th Annual Congress of the European Association of Urology, Copenhagen, Denmark, 2018/3/26

  2. 欧州泌尿器科学会ベストポスター賞
    J. Ishioka, Y. Matsuoka, S. Uehara, Y. Yasuda, T. Kijima, S. Yoshida, M. Yokoyama, K. Saito, K. Kihara, T. Kimura, K. Kudo, I. Kumazawa, Y. Fujii. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. "Best Poster Presentation", The 33th Annual Congress of the European Association of Urology, Copenhagen, Denmark, 2018/3/26

  3. 第106回日本泌尿器科学会総会 総会賞
    Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.
    Novel therapy targeting androgen receptor splice variants by inhibiting heat shock factor 1 (HSF1) for the treatment of castration-resistant prostate cancer. 2018年4月19日

  4. 第626回日本泌尿器科学会東京地方会ベストプレゼンテーション賞
    相馬 貴彦、安田 庸輔、木島 敏樹、倉田 盛人、金子 香澄、福田 悠一、矢嶋 習吾、戸出 真宏、福田 翔平、早稲田 悠馬、上原 翔、吉田 宗一郎、横山 みなと、石岡 淳一郎、松岡 陽、齋藤 一隆、木原 和徳、藤井 靖久. Cushing症候群を呈しアドステロールシンチグラフィ 陰性であった副腎black adenomaの1例. 第626回日本泌尿器科学会東京地方会、2018年2月16日

原著

  1. Moriyama S, Yoshida S, Tanaka H, Tanaka H, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int J Urol, 2018. PubMed

  2. Uehara S, Yoshida S, Tanaka H, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol Int, 100(1): 85-91, 2018. PubMed

  3. Fukushima H, Kataoka M, Nakanishi Y, Sakamoto K, Takemura K, Suzuki H, Ito M, Tobisu KI, Fujii Y, Koga F. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy. Urol Oncol, 36(4): 156.e9-16, 2018. PubMed

  4. Fukushima H, Kobayashi M, Kawano K, Morimoto S. Prognostic Value of Albumin/Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy. Anticancer Res, 38(4): 2329-34, 2018. PubMed

総説

  1. Fujii Y. Prediction models for progression of non-muscle-invasive bladder cancer: A review. Int J Urol, 25(3): 212-8, 2018. PubMed

学会発表

国際前立腺と腎臓癌の部分治療と画像会議(The 10th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer, Noordwijk, The Netherlands)
  1. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Predictive significance of MRI-targeted biopsy for pathological and oncological outcomes after radical prostatectomy. 2018/2/12

  2. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Prognostic impact of prostate imaging reporting and data system scores on oncological outcome. 2018/2/12

欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark)
  1. Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Kimura T, Kudo K, Kumazawa I, Fujii Y. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 2018/3/16

  2. Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y.Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 2018/3/17

  3. Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Favorable locoregional control in patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy with lymph node dissection. 2018/3/18

  4. Fukushima H, Kobayashi M, Kwano K, Morimoto S. SOFA and quick SOFA are more clinically useful scoring systems than SIRS in predicting mortality of patients with acute pyelonephritis associated with upper urinary tract calculi. 2018/3/18

  5. Fukushima H, Kobayashi M, Kwano K, Morimoto S. Lower performance status is a risk factor for sepsis of patients with acute pyelonephritis associated with upper urinary tract calculi in the Sepsis-3 era. 2018/3/18

  6. Yajima S, Yoshida S, Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. 2018/3/19

  7. Soma T, Yoshida S, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. The usefulness of diffusion-weighted MRI in the differential diagnosis of urachal disorders. 2018/3/19

  8. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. 2018/3/19

  9. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades. 2018/3/19

  10. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy. 2018/3/19

  11. Yoshida S, Takahara T, Ishii C, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. METastasis reporting and data system for prostate cancer score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. 2018/3/19

  12. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. 2018/3/19

  13. Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction. 2018/3/19

  14. Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system. 2018/3/19

  15. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. 2018/3/19